This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4llw
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==Crystal structure of Pertuzumab Clambda Fab with variable domain redesign (VRD2) at 1.95A== | ==Crystal structure of Pertuzumab Clambda Fab with variable domain redesign (VRD2) at 1.95A== | ||
<StructureSection load='4llw' size='340' side='right' caption='[[4llw]], [[Resolution|resolution]] 1.95Å' scene=''> | <StructureSection load='4llw' size='340' side='right' caption='[[4llw]], [[Resolution|resolution]] 1.95Å' scene=''> | ||
| Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4llu|4llu]], [[4lld|4lld]], [[4llm|4llm]], [[4llq|4llq]], [[4lly|4lly]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4llu|4llu]], [[4lld|4lld]], [[4llm|4llm]], [[4llq|4llq]], [[4lly|4lly]]</td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4llw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4llw OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4llw RCSB], [http://www.ebi.ac.uk/pdbsum/4llw PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4llw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4llw OCA], [http://pdbe.org/4llw PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4llw RCSB], [http://www.ebi.ac.uk/pdbsum/4llw PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4llw ProSAT]</span></td></tr> |
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
| Line 15: | Line 16: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4llw" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 21:22, 11 August 2016
Crystal structure of Pertuzumab Clambda Fab with variable domain redesign (VRD2) at 1.95A
| |||||||||||
Categories: Human | Atwell, S | Chamberlain, A K | Demarest, S J | Guntas, G | Hansen-Estruch, C | Ho, C | Huang, F | Kuhlman, B | Leaver-Fay, A | Lewis, S M | Pustilnik, A | Sereno, A | Smith, E M | Truhlar, S M | Wu, X | Fab | Immune system
